Clinical Medicine Research Institute, First Affiliated Hospital of Jinan University, Guangzhou, China; Laboratory of Neuroendocrinology, School of Biological Sciences, Fujian Normal University, Fuzhou, China.
Digestive Disease Institute of Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Cell Mol Gastroenterol Hepatol. 2020;9(1):145-160. doi: 10.1016/j.jcmgh.2019.09.002. Epub 2019 Sep 25.
BACKGROUND & AIMS: Toll-like receptor 2 (TLR2) and TLR3 regulate hepatic immunity under pathological conditions, but their functions and potential drug targets in alcoholic liver disease (ALD) remain poorly understood.
ALD-associated liver injury were induced in TLR2 knockout (TLR2), TLR3, TLR2 bone marrow transplanted (BMT), TLR3 BMT, IL-10 mice, and their wild-type littermates through ethanol challenge with or without co-administered epigallocatechin-3-gallate (EGCG). Moreover, Kupffer cells were depleted by GdCl injection to evaluate their pathogenic roles in ALD.
We identified that deficiency of TLR2 and TLR3 significantly alleviated and aggravated ALD-induced liver injury, respectively. Mechanistically, Kupffer cell inactivation, M1 to M2 polarization, and IL-10 production via STAT3 activation contributed to hepatic protection mediated by concurrent TLR2 inhibition and TLR3 agonism. These findings were further confirmed in TLR2 and TLR3 BMT mice. We also identified a novel ALD-protective agent EGCG which directly interacted with Kupffer cell TLR2/3 to induce IL-10 production. Deficiency of IL-10 aggravated ALD injury and blunted EGCG-mediated hepatoprotection while depletion of Kupffer cells partially recovered liver injury but abolished EGCG's actions.
Altogether, our results illustrate the divergent roles of Kupffer cells TLR2/3 in ALD progression via anti-inflammatory cytokine IL-10 production.
Toll 样受体 2(TLR2)和 TLR3 在病理条件下调节肝脏免疫,但它们在酒精性肝病(ALD)中的功能和潜在药物靶点仍知之甚少。
通过乙醇联合或不联合表没食子儿茶素没食子酸酯(EGCG)给药,在 TLR2 敲除(TLR2)、TLR3、TLR2 骨髓移植(BMT)、TLR3 BMT、IL-10 小鼠及其野生型同窝仔鼠中诱导与 ALD 相关的肝损伤。此外,通过注射钆氯化物耗竭库普弗细胞,以评估其在 ALD 中的致病作用。
我们发现 TLR2 和 TLR3 的缺失分别显著减轻和加重了 ALD 诱导的肝损伤。在机制上,库普弗细胞失活、M1 向 M2 极化以及通过 STAT3 激活产生的 IL-10 导致 TLR2 抑制和 TLR3 激动剂同时作用介导的肝脏保护。这些发现进一步在 TLR2 和 TLR3 BMT 小鼠中得到证实。我们还鉴定出一种新型的 ALD 保护剂 EGCG,它直接与库普弗细胞 TLR2/3 相互作用诱导 IL-10 产生。IL-10 缺乏加重了 ALD 损伤并减弱了 EGCG 介导的肝保护作用,而库普弗细胞耗竭部分恢复了肝损伤但消除了 EGCG 的作用。
总之,我们的结果说明了库普弗细胞 TLR2/3 通过抗炎细胞因子 IL-10 产生在 ALD 进展中的不同作用。